Select IP with Hogan Lovells | Webinar no.2 'Injunctions & Remedies (Part II)'

Our second session on Injunctions & Remedies (Part II) covered China, Russia, Germany, Spain and Italy, with Dr Frederick Ch'en, Katie Feng, Natalia Gulyaeva, Dr Andreas von Falck, Ana...

2020 SEPs and FRAND Year in Review

In 2020, we continued to see heated discussions around standard essential patents (SEPs) and FRAND licensing of SEPs globally. Especially, the recent decisions from the highest courts in...

How to weather the storm: bolstering your brands in challenging times in the U.S. and Europe

We are delighted to invite you to our series of webinars designed to help companies in Greater China navigate the ever-evolving markets in the U.S. and Europe.

Trade Secret Protection in China after the U.S.-China Phase One trade deal

As part of the U.S.-China Phase One trade deal that was signed on 15 January 2020, China agreed to strengthen its intellectual property (IP) protection in several ways. Most significantly,...

Tokyo: Life Sciences and Health Care Horizons 2019

Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.

Tokyo: Life Sciences and Health Care Horizons 2019

Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.

Sailing the international market and building an innovative ecosystem

On 27 June, Hogan Lovells, associated office Hogan Lovells Fidelity, and Fujian Fidelity Law Firm successfully co-hosted the international intellectual property forum titled "Sailing the...

Loading data